Immune correlates against SARS-CoV-2 infection – results of population and hospital-based studies in the IMMUNEBRIDGE project in Germany, 2022 HARRIE S Manuela , Berit Lange , Maren Dreier , Veronika Jäger , André Karch , Viktoria Rücker , Hendrik Streeck , Sabine Blaschke , Astrid Pestersmann , Nicole Toepfner , Matthias Nauck , Isbell Vonholt , Axel Budde , Antonia Bartz , Marc Kurosins , Reinhard Berner , Max Borsche , Gunnar Brandhorst , Melanie Brinkmann , Kathrin Budde , Marek Deckena , Géraldine Engels , Marc Flenzlaff , Christoph Härtel , Olga Hovardovska , Alexander Katalinic , Katja Kehl , Mirjam Kohls , Stefan Krüger , Wolfgang Lieb , Tobias Pischon , Daniel Rosenkranz , Nicole Rübsamen , Jan Rupp , Christian Schäfer , Mario Schattschneider , Anne Schlegtendal , Simone Schlinkert , Lena Schmidbauer , Kai Schulze-Wundling , Stefan Störk , Carsten Tiemann , Henry Völzke , Theresa Winter , Christine Klein , Johannes G. Liese , Folke Brinkmann , Patrick Frank Ottensmeyer , Jens‐Peter Reese , Peter U. Heuschmann Gesundheitswesen（2023）
摘要
Einleitung In spring 2022, Germany lacked systematically collected population-based SARS-CoV-2 data allowing real-time assessment of protection levels against severe course of COVID-19. To fill this gap, the IMMUNEBRIDGE project, a joint collaboration of eight population- and one hospital-based studies, was launched.
更多 查看译文
关键词
immune, immunebridge project, infection, sars-cov, hospital-based
AI 理解论文
溯源树
样例
